Structured Deals Are Eating Venture Capital’s Founder-Friendly Terms

On a Tuesday in late April, a Series B company in the enterprise infrastructure space closed a $52 million round led by a tier-one Bay Area fund. The press release framed it as a clean up-round from a prior $180 million post-money valuation. What the release omitted was the participation cap embedded in the Series B preferred, a 2x liquidation preference with a 20 percent cumulative dividend that accrues quarterly, and a board seat that came with a veto on any future down-round re-pricing. Three different attorneys who reviewed the final docs independently described the same clause as "the kind of structure you would expect in a distressed recapi­talization, not a growth round." The company is not distressed. Revenue grew 70 percent year over year. The lead simply had the leverage and used it.

That deal is not an outlier. Across venture capital in 2026, the structured deal is back, and it is back with a specificity that makes the founder-friendly term sheets of 2021 look like a different century. The mechanics are the story: participation rights that let preferred investors double-dip on exit proceeds, cumulative dividends that compound silently on the cap table, anti-dilution ratchets calibrated to full-ratchet rather than weighted-average, and redemption provisions that start the clock ticking after five years. In the Crunchbase News quarterly report published in April, Mary Ann Azevedo documented that global fintech funding rose year over year in Q1 2026 while deal count fell sharply. The capital is concentrating. And when capital concentrates, the investors writing the checks write the terms.

The shift is not happening in a vacuum. T. Rowe Price Group, the $1.6 trillion Baltimore-based asset manager that has spent the past decade building out a private-markets franchise alongside its public mutual-fund business, reported first-quarter 2026 earnings on May 1 that showed investment advisory fees rising even as assets under management slipped on market volatility. The firm's executives used the earnings call to flag continued expansion into alternative assets, including collateralized loan obligations, which T. Rowe entered as an issuer in April. The significance for venture capital is indirect but material: when one of the world's largest crossover investors is diversifying into structured credit instruments, the same analytical machinery migrates into how its private-technology allocation team thinks about downside protection on a late-stage round.

The rise of structured terms reflects a market where pricing power has flipped from founder to funder, and the flips are happening at the margins that press releases do not photograph. A $40 million seed round made headlines in March; the post-money was $210 million, which implies a pre-money of $170 million for a company with eight months of live product data.

To be clear, structured equity is not new. Preferred stock with liquidation preferences has been the standard architecture of venture capital since the 1970s. What is changing is the density of the structure, the number of protective provisions layered into a single security, and the stage at which those provisions appear. Terms that would have been considered aggressive for a late-stage pre-IPO round in 2019 are now showing up in Series A term sheets.

The explanation is partly cyclical and partly structural. The cyclical part is straightforward: venture returns have been lousy. Distributions to LPs hit a fifteen-year low in 2024 and recovered only modestly in 2025, according to data from Cambridge Associates. Funds raised in the 2019-2022 vintages are sitting on portfolios valued at marks that predate the rate-hiking cycle, and GPs are under pressure to show DPI, the distribution-to-paid-in ratio, before they can go back to market for their next fund. Structured terms are a way to engineer a narrower distribution of outcomes: if the exit is modest, the fund still gets paid. If the exit is enormous, the fund gets paid twice. The structural explanation is that limited partners, stung by the denominator effect and burned by mark-to-model valuations, are demanding it.

The Michael Saylor strategy, in a sense, is the public-market mirror of this trend. Strategy, the company formerly known as MicroStrategy, has been issuing convertible notes to buy Bitcoin since 2020, a capital-structure maneuver that converts equity upside into a debt instrument with a conversion premium. Saylor told investors in February that the company faces no liquidation risk unless Bitcoin drops to roughly $8,000, a level so far below current trading that the statement functions as a boast about the resilience of the structure. The parallel to venture capital is not the asset class, it is the engineering: Saylor is using structured financing to manage downside while preserving upside exposure to a volatile asset, which is exactly what a venture fund does when it writes a participating preferred into a startup that might either be worth nothing or ten billion dollars. The difference is that Saylor's structure is disclosed in SEC filings. The startup equivalent is buried in the amended and restated certificate of incorporation, which no journalist reads and few founders understand until the exit waterfall hits their bank account.

The lead's $40 million could theoretically claim a share of common-stock proceeds even after collecting its preference. That is not a seed round, that is a structured credit position dressed in equity clothing., GP at a venture firm that passed on a $40M seed round, March 2026

The mechanics worth watching are not always the ones founders are trained to fear. Founders obsess over valuation; a higher pre-money number feels like a win. But a $500 million pre-money with a 3x participating preferred and a 6 percent cumulative dividend can leave common stockholders with nothing on an exit below $1.5 billion, while a $350 million pre-money with a straight 1x non-participating preferred would return meaningful value to founders and employees at a $600 million exit. The lawyers who negotiate these deals say the sophistication gap between what the lead's counsel knows and what the company's counsel knows is widening. "I have seen three deals in the past quarter where the founder's attorney did not flag the difference between broad-based and narrow-based weighted-average anti-dilution," said one partner at a boutique firm that represents startups. "That difference is worth tens of millions of dollars at the Series C markdown."

The Crunchbase data bears this out structurally. The Q1 2026 numbers show that while total dollars deployed into fintech startups rose meaningfully year over year, the number of deals fell. The same pattern holds across AI infrastructure, enterprise SaaS, and climate tech: fewer companies are raising, but the ones that are raising are raising more, and the rounds are taking longer to close. When the pool of funded companies shrinks, the ones outside the pool grow desperate, which gives the ones inside the pool the illusion of safety. The illusion is that their terms are market, when in fact the market has bifurcated between a handful of companies that can command clean terms and everyone else who is being asked to sign structures that would have been unthinkable three years ago.

The JD Supra analysis published by Mayer Brown in March, "Preferred Equity: Comparing Alternatives and Managing Legal Risks," is nominally about private equity and real estate but its framework applies directly to venture. The authors walk through the hierarchy of preferred equity in the capital structure: it sits above common equity but below all debt, and its protections are only as strong as the covenants that define them. The analysis notes a growing trend toward what it calls "structured preferred," instruments that blend fixed-income characteristics with equity upside, including paid-in-kind dividends, make-whole provisions, and put rights. The vocabulary is migrating from the private equity playbook into the venture term sheet, and it is doing so without much public attention because the parties who benefit from opacity have no incentive to change the lighting.

What the GPs are saying off the record

In conversations over the past month with a dozen GPs at funds ranging from $150 million seed vehicles to $3 billion multi-stage platforms, a pattern emerged. The GPs who are deploying structured terms defend them as fiduciary discipline. "We are protecting our LPs from the valuation excesses of 2021, and if that means we need a 2x liquidation preference to justify the entry price, that is what we do," said one partner at a fund that closed a $700 million vehicle last year. The GPs who are losing deals to structured bids describe the same mechanics as "predatory" and "short-termist." The firm that wins is the one with the capital, and in 2026, capital is increasingly held by a shrinking number of large multi-stage platforms and crossover funds. The lead fund, contacted for comment, did not respond.

The Forbes TrueBridge Capital Partners report released in March framed 2026 as "the value creation era," a term that sounds anodyne until you translate it into the language of term sheets. Value creation, in this context, means that investors are no longer underwriting to terminal value on the assumption that growth will bail out a bad entry price. They are underwriting to the structure. The report noted that median pre-money valuations increased across stages in 2025, but the composition of those valuations changed: a higher share of total consideration is now flowing through preferred-stock terms rather than common-stock value. That is the same phenomenon, viewed from a different angle. When the headline valuation stays flat or rises but the effective valuation for common stockholders falls, the difference is being absorbed by the structure.

The T. Rowe Price quarterly filing contains a detail that sharpens the picture. The firm reported net client outflows of $18.3 billion for the quarter, continuing a pattern of structural outflows that Seeking Alpha's analysis pegged at $272 billion cumulatively since 2021. The firm is compensating by leaning into higher-fee alternative products, including private credit and private equity co-investment. For venture-backed companies, that means one of the largest pools of late-stage capital is becoming more return-sensitive and more terms-sensitive at the same moment that IPO markets remain selective and M&A exits remain sluggish. The liquidity crunch that was supposed to resolve in 2024 and then in 2025 has now been pushed into the second half of 2026, according to three bankers at major technology practices, and every quarter that the window stays narrow is a quarter in which structured terms compound on the cap table. Cumulative dividends do not disappear because the exit takes longer; they accrue.

There is a specific clause that illustrates the asymmetry better than most: the MFN, or most-favored-nation provision, which is increasingly being written into convertible notes and SAFEs issued during bridge rounds. In a standard MFN, if the company subsequently raises a priced round on better terms than the bridge, the bridge investors get the benefit of those better terms. The new variant, which two attorneys described as increasingly common in 2026 bridge rounds, is an MFN with a floor but no cap, meaning the bridge investors get the benefit of any subsequent improvement in terms but are protected from any deterioration.

The structured deal is not going away. It is the logical response to a market where capital is abundant for a small number of perceived winners and scarce for everyone else, where exit timelines have stretched to a decade or more, and where LPs are demanding evidence of risk management rather than promises of grand slam returns. For founders, the practical implication is that the term sheet matters more than the headline number, and the difference between a good outcome and a wipeout at exit is often a handful of clauses that nobody reads aloud at the closing dinner. For the venture industry, the rise of the structured deal raises a question that no GP wants to answer on the record: if you need a 3x liquidation preference and a cumulative dividend to make your return model work, what are you actually saying about the price you paid?

The next checkpoint comes in the third quarter, when a wave of 2023-vintage bridge rounds are scheduled to mature or convert. Several of those bridges carry the MFN-plus-floor structures described above. How the conversion mechanics play out, and whether the pricing terms trigger a cascade of anti-dilution adjustments across the cap table, will tell us whether the structured deal is a temporary feature of a tight market or a permanent re-architecture of how venture capital allocates risk between investors and founders. The lawyers are already drafting the amendments. The LPs are reading the term sheets. The founders, for the most part, are still looking at the pre-money.